About Bionovo (OTCMKTS:BNVIQ)
Bionovo, Inc. is a drug discovery and development company, which focuses on women's health and development of drugs for the treatment of cancer. The Company's drug candidates include Menerba, Seala, Bezielle, BN107 and BN108. Its Menerba is a selective estrogen receptor beta agonist, which reduces the frequency and severity of menopausal hot flashes. The Company has completed a randomized, double-blind, placebo-controlled Phase II clinical trial of Menerba. Bezielle is an orally delivered anti-cancer agent. The Company is engaged in an open label, multi-center Phase I/II trial of Bezielle for the treatment of advanced metastatic breast cancer. The Company's Seala is a selective estrogen receptor beta agonist, which acts as an intra-vaginal suppository. The Company's anti-cancer agents include BN107 and BN108, which are used for the treatment of advanced breast cancer. BN107 and BN108 are in pre-clinical development stage.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on Equity-417.31%
Return on Assets-204.78%
Bionovo (OTCMKTS:BNVIQ) Frequently Asked Questions
What is Bionovo's stock symbol?
Bionovo trades on the OTCMKTS under the ticker symbol "BNVIQ."
Has Bionovo been receiving favorable news coverage?
Media headlines about BNVIQ stock have trended positive this week, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Bionovo earned a news sentiment score of 0.46 on Accern's scale. They also gave news coverage about the healthcare company an impact score of 45.01 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future.
How do I buy shares of Bionovo?
Shares of BNVIQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Bionovo's stock price today?
One share of BNVIQ stock can currently be purchased for approximately $0.0003.
How can I contact Bionovo?
Bionovo's mailing address is 5858 Horton St Ste 400, EMERYVILLE, CA 94608-2046, United States. The healthcare company can be reached via phone at +1-510-6012000.
MarketBeat Community Rating for Bionovo (BNVIQ)MarketBeat's community ratings are surveys of what our community members think about Bionovo and other stocks. Vote "Outperform" if you believe BNVIQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BNVIQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
Bionovo (OTCMKTS:BNVIQ) Analyst Ratings History
(Data available from 4/26/2016 forward)
Bionovo (OTCMKTS:BNVIQ) Earnings History and Estimates Chart
Bionovo (OTCMKTS BNVIQ) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Bionovo (OTCMKTS:BNVIQ) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Bionovo (OTCMKTS BNVIQ) Insider Trading and Institutional Ownership History
Bionovo (OTCMKTS BNVIQ) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Bionovo (OTCMKTS BNVIQ) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Bionovo (OTCMKTS:BNVIQ) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Bionovo (OTCMKTS BNVIQ) Stock Chart for Thursday, April, 26, 2018